Women's Health

New research reveals consequences of long pregnancies

A new report highlights the importance of women giving birth as close to their due dates as possible, as pregnancies that run over 40 weeks present added risk to both maternal and newborn health. Researchers from Tel Aviv University in Israel found that babies born after 42 weeks in the womb were...

Doctors' approach to HIV testing 'needs to change'

Doctors could encourage greater take-up of HIV testing by changing the way they approach patients about the matter, according to new research. Figures indicate that around 37 million people are living with HIV throughout the world, but almost half (46 per cent) of cases have not yet been diagnosed...

Intensive therapy linked to a fall in HIV infections

Frequent testing followed by treatment with antiretroviral therapy (ART) could see HIV infection rates cut by 66 per cent, new research has suggested. Researchers in the Netherlands studied a number of men who have had sex with other men that were newly infected with HIV - a group that has recorded...

New treatment could help suppress HIV

The use of a technique known as 'passive immunisation' could help play a role in suppressing the effects of HIV, researchers have claimed. A large collaboration of researchers published findings earlier this December that suggested the use of an antibody, called VRC01, could help to...

Anti-HIV condom 'could be released next year'

A 'super condom' boasting anti-HIV properties could be on sale to the public as soon as next year, scientists have claimed. The contraceptive, developed by a team from the Texas A&M Health Science Center, USA, is made from an elastic polymer called hydrogel and contains plant-based...

HIV drugs 'not reaching many African patients'

The process of supplying potentially lifesaving antiretroviral drugs to HIV -positive patients in areas of sub-Saharan Africa is routinely falling short, a new study has claimed. A recent report from Medicins Sans Frontiere (MSF) claims that despite a rich stock, many of the necessary drugs are not...

HIV treatment given Euro green light

European regulators have approved the use of Gilead's Genvoya for the treatment of HIV . The drug gives adults access to what is a novel, once-daily, single-tablet that helps to suppress the virus and provide long-term health benefits for patients. The therapy is the first tenofovir alafenamide...

Lack of Vitamin D could hamper HIV treatment

Effectiveness of HIV treatment in adults may be hampered by low levels of vitamin D, new research has suggested. A study published in the journal Clinical Nutrition found that while many HIV positive sufferers are capable of living a long and healthy life, others see their immune system decline...

Stem cell technology being trialled for HIV cure

The world's first clinical trial to treat HIV -positive patients with blood transplants from the umbilical cord over three years is set to start in Spain. The goal of the study is to try and build on accounts of what some claimed to be the first man to be cured of the virus, Timothy Ray Brown,...

India set for cheaper HIV medicines

Patients in India may soon benefit from cheaper HIV medicine, as the government is reconsidering the formula used to fix its rates. As well as HIV patients, those suffering from TB, diabetes and cancer could all benefit, although there is a potential caveat. While low prices would benefit the...